Assessment in Severe Dementia: The Guy's Advanced Dementia Schedule

Ward, Tony; Dawe, Bridget; Procter, Andrew W.; Murphy, Elaine; Weinman, John

doi:10.1093/ageing/22.3.183

Cited by 12 publications

(9 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Dementia researchers should reach international consensus about the terminology and operational definition of late dementia, to consolidate and compare studies. Designs should be developed to follow dementia patients until late dementia, and assessment scales should be constructed that will measure slight changes in this phase of the disease, such as changes in emotional expression or responding to stimulation 18–21 …”

Section: Discussionmentioning

confidence: 99%

Survival to Late Dementia in Dutch Nursing Home Patients

Koopmans

Ekkerink

Weel

2003

J American Geriatrics Society

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Survival to Late Dementia in Dutch Nursing Home Patients

Koopmans

Ekkerink

Weel

2003

J American Geriatrics Society

View full text Add to dashboard Cite

show abstract

“…• Cognitive functioning: Guy's Advanced Dementia Schedule [32]; a structured assessment of cognitive ability that involves measuring responses to familiar objects. [In the initial funding application we proposed to use the Severe Impairment Battery [33], but as initial piloting indicated floor effects on this measure we replaced it with the GADS.…”

Section: Stage Two Development Of the Awareness Measurementioning

confidence: 99%

Development of an awareness-based intervention to enhance quality of life in severe dementia: trial platform

Clare

Woods

Whitaker

et al. 2010

Trials

View full text Add to dashboard Cite

BackgroundQuality of residential care for people with severe dementia is in urgent need of improvement. One reason for this may be the assumption that people with severe dementia are unaware of what is happening to them. However, there is converging evidence to suggest that global assumptions of unawareness are inappropriate. This trial platform study aims to assist care staff in perceiving and responding to subtle signs of awareness and thus enhance their practice.Methods/DesignIn Stage One, a measure of awareness in severe dementia will be developed. Two focus groups and an expert panel will contribute to item and scale development. In Stage Two observational data will be used to further develop the measure. Working in four care homes, we will recruit 40 individuals with severe dementia who have no, or very limited, verbal communication. Data on inter-rater reliability and frequency of all items and exploratory factor analysis will be used to identify items to be retained. Test-retest and inter-rater reliability for the new measure will be calculated. Correlations with scores for well-being and behaviour and with proxy ratings of quality of life will provide an indication of concurrent validity. In Stage Three the new measure will be used in a single blind cluster randomised trial. Eight care homes will participate, with 10 residents recruited in each giving a total sample of 80 people with severe dementia. Homes will be randomised to intervention or usual care conditions. In the intervention condition, staff will receive training in using the new measure and will undertake observations of designated residents. For residents with dementia, outcomes will be assessed in terms of change from baseline in scores for behaviour, well-being and quality of life. For care staff, outcomes will be assessed in terms of change from baseline in scores for attitudes, care practice, and well-being.DiscussionThe results will inform the design of a larger-scale trial intended to provide definitive evidence about the benefits of increasing the sensitivity of care staff to signs of awareness in residents with severe dementia.Trial RegistrationISRCTN59507580 http://www.controlled-trials.com.

show abstract

“…COPD effects on cognition are still poorly understood; indeed, this comorbidity has not been investigated as extensively as other pathologies 10–13. Cognitive function impairment was found to be associated with severe pulmonary dysfunction long ago,14–19 although its prevalence varied from study to study20–23 and was dependent on the specific diagnostic criteria adopted, the methods used for assessing the impairment, and the number of subjects investigated 12,24,25. Several studies investigating cognition in subjects with chronic airflow limitation had methodological limitations, including lack of clinical assessment of airflow impairment;26 a specific focus on cognitive impairment in elderly subjects with severe respiratory conditions; a lack of interest in subjects without a defined respiratory disease;20,27–29 a lack of extensive comparison of cognitive impairment in COPD subjects versus subjects with other chronic airway disorders and/or healthy subjects;23,29 a lack of multiple psychometric tools;30 and small sample sizes 7,21,31,32…”

Section: Introductionmentioning

confidence: 99%

Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values

Rw¹,

Bonadiman²,

Tognella³

et al. 2014

COPD

View full text Add to dashboard Cite

BackgroundChronic obstructive pulmonary disease (COPD) can affect cognition. The effects of other less severe chronic airway disorders on cognition remain to be clarified. This study aimed to measure and compare cognitive deterioration in subjects with COPD, subjects with chronic non-obstructive bronchitis (CNOB), and asymptomatic smokers (AS), and to relate the corresponding prevalence to several demographic and clinical variables and to normal reference values.MethodsFour hundred and two subjects (COPD n=229, CNOB n=127, and AS n=46) of comparable age were included in the study. Cognitive impairment was assessed using the Mini Mental Status test, the Clock Drawing test, and the Trail Making test A and B.ResultsThe extent and prevalence of cognitive deterioration was greater in COPD subjects, followed by CNOB subjects and AS (P<0.001). The Medical Research Council and COPD Assessment test scores, forced expiratory volume in the first second predicted, and arterial partial pressure of O2 and of CO2 were related to the extent and the prevalence of cognitive deterioration. COPD subjects, CNOB subjects, and AS aged 40–69 years showed the greatest cognitive impairment (P<0.01 compared to normal values). This was particularly clear in COPD subjects.ConclusionCognitive impairment may start at the early stages of chronic airway damage and progress with a worsening of the respiratory condition. Indeed, the greatest cognitive deterioration was seen in COPD subjects. Cognition impairment may contribute to explaining the insufficient adherence to therapeutic plans and strategies, and the increasing social costs in respiratory subjects.

show abstract

Assessment in Severe Dementia: The Guy's Advanced Dementia Schedule

Cited by 12 publications

References 0 publications

Survival to Late Dementia in Dutch Nursing Home Patients

Survival to Late Dementia in Dutch Nursing Home Patients

Development of an awareness-based intervention to enhance quality of life in severe dementia: trial platform

Extent and prevalence of cognitive dysfunction in chronic obstructive pulmonary disease, chronic non-obstructive bronchitis, and in asymptomatic smokers, compared to normal reference values

Contact Info

Product

Resources

About